-
-
-
-
-
-
-
Charles River to provide NGS services for Arovella cancer therapy
-
-
-
-
-
-
-
Jefferies finds AI drives up to 50% cost cuts in drug development
-
-
-
-
-
-
-
Barclays: Life science insiders sold $187M in stock during first quarter
-
-
-
-
-
-
-
Charles River to acquire two companies for $570 million total
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q3 EPS by 9c ; Offers Guidance
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY25 EPS Guidance
-
-
-
-
-
-
-
Evercore ISI Upgrades Charles River Labs (CRL) to Outperform
-
455,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

